Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-04

Clinical Trial Update: A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial of PRT-064040 nasal spray in healthy adults for migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRT-064040 nasal spray (PRT-064040)

Snippet

Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. | Conditions: Migraine | Phase 1 | Status: COMPLETED